Overview
Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy
Status:
Completed
Completed
Trial end date:
2017-04-01
2017-04-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The primary objective is to describe the safety and efficacy of intravenous sodium fluorescein to visualize ureteral efflux during intraoperative cystoscopy after total laparoscopic hysterectomy. Secondary objective is to report on surgeon's satisfaction with the overall use of sodium fluorescein.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Centre Hospitalier Universitaire de Québec, CHU de Québec
CHU de Quebec-Universite Laval
Criteria
Inclusion Criteria:- total laparoscopic hysterectomy
Exclusion Criteria:
- breastfeeding
- renal insufficiency
- Medication: Probenecid, digoxin, quinidine, beta-blocker
- hypersensitivity or intolerance to sodium fluorescein